Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: Identification of a novel inducible inhibitor

Endocrinology

Volumn 143, Issue 4, 2002, Pages 1199-1205

  Chen, Bing Kun ^a   Overgaard, Michael T ^b   Bale, Laurie K ^a   Resch, Zachary T ^a   Christiansen, Michael ^c   Oxvig, Claus ^b   Conover, Cheryl A ^a  

^a MAYO CLINIC   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; SOMATOMEDIN BINDING PROTEIN 4;

ANTIGEN EXPRESSION; ARTICLE; COCULTURE; COMPLEX FORMATION; DISULFIDE BOND; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKIN FIBROBLAST; TUMOR GROWTH;

EID: 0036204207     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.4.8729     Document Type: Article

References (33)

1. Insulinlike growth factor-binding protein proteolysis: An emerging paradigm in insulinlike growth factor physiology
2. Posttranslational modification of the IGF binding proteins
3. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action
4. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein
5. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions
6. Regulation of insulin-like growth factor binding protein-4 by a specific insulin-like growth factor binding protein-4 protease in normal human osteoblast-like cells: Implications in bone cell physiology
7. Insulin-like growth factor II enhancement of cell growth via a nonreceptor-mediated mechanism
8. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF binding protein-4 proteolysis and expression of protease-resistant IGF binding protein-4 mutants
9. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4
10. Posttranslational regulation of insulin-like growth factor (IGF) binding protein-4 in normal and transformed human fibroblasts: IGF dependence and biological studies
11. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases
12. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells
13. Effect of follide stimulating hormone and insulin-like growth factors on proteolysis of insulin-like growth factor binding protein-4 in human granulosa cells
14. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A
15. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A
16. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty
17. Phorbol ester tumor promoters regulate insulin-like growth factor binding protein-4 proteolysis
18. Alterations in insulin-like growth factor (IGF)-dependent IGF binding protein-4 proteolysis in transformed osteoblastic cells
19. A novel method for real time quantitative RT-PCR
20. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein
21. Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/pro-MBP) complex in first-trimester maternal serum screening for Down syndrome
22. Biological characterization of human epithelial ovarian carcinoma cells in primary culture: The insulin-like growth factor system
23. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein
24. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor
25. Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein
26. The insulin-like growth factor binding protein-4 (IGFBP-4)/IGFBP-4 protease system in normal human osteoblast-like cells: Regulation by transforming growth factor-β
27. Characterization of four human pregnancy-associated plasma proteins
28. Acidic precursor revealed in human eosinophil granule major basic protein cDNA
29. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta
30. Complete cDNA sequence of the preproform of human pregnancy-associated plasma protein-A. Evidence for expression in the brain and induction by cAMP
31. The 21-kDa protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts
32. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins
33. Signal perception and transduction: The role of protein kinases